Walgreens Boots Alliance Appoints William H. Shrank, M.D., to Board of Directors
July 10 2024 - 5:05PM
Business Wire
Dr. Shrank brings extensive healthcare
experience, business leadership and clinical expertise to WBA board
as the company undergoes strategic turnaround
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the
appointment of William H. Shrank, M.D., to the company’s board of
directors. Dr. Shrank is globally recognized for his leadership and
expertise in healthcare strategy, policy and population health. He
joins the WBA board at an important time as the company strengthens
its business.
Currently, Dr. Shrank is a venture partner with the Bio + Health
Team of Andreesen Horowitz, a private venture capital firm, a role
he has held since January 2023. He previously served in a number of
senior leadership roles with Fortune 50 companies including Chief
Medical Officer (CMO) for Humana, Inc. and Chief Scientific Officer
and CMO of Provider Innovation for CVS Health.
“Dr. Shrank is a strategic, experienced healthcare leader and I
am proud to have him on our board as we execute the turnaround plan
for our business,” said Tim Wentworth, Walgreens Boots Alliance
CEO. “As the healthcare and retail landscapes continue to evolve
and we further enhance our focus and sharpen execution, I am
confident that his background will help us elevate the value of
community pharmacy and unlock opportunities for our long-term
strategy.”
“I am pleased to welcome Dr. Shrank to the WBA Board of
Directors,” said Stefano Pessina, Executive Chairman, Walgreens
Boots Alliance. “I look forward to working with Dr. Shrank and know
that his clinical and business insights, experience and
patient-centric approach will be a strong asset for WBA driving
long-term value for our patients, customers and shareholders.”
Prior to joining Andreesen Horowitz, Dr. Shrank served as Chief
Medical Officer of Humana Inc., a leading care delivery and health
plan administration company, from April 2019 to August 2022. His
responsibilities included implementing Humana’s integrated care
delivery strategy with an emphasis on advancing the company’s
clinical capabilities and improving the health outcomes of its
members. He also led Humana’s Care Delivery Organization, clinical
operations and population health strategy.
Previously, Dr. Shrank served as Chief Medical Officer,
Insurance Services Division, of the University of Pittsburgh
Medical Center (UPMC) from April 2016 to February 2019. From 2013
to 2016, Dr. Shrank held several leadership positions with CVS
Health Corporation, including Senior Vice President, Chief
Scientific Officer, and Chief Medical Officer of Provider
Innovation. He also worked for the Center for Medicare and Medicaid
Innovation, part of the Centers for Medicare and Medicaid Services
(CMS), as Director, Research and Rapid-Cycle Evaluation Group.
Dr. Shrank began his career as a practicing physician with
Brigham and Women’s Hospital in Boston, Mass. and as an assistant
professor at Harvard Medical School. He received his B.A. in
Psychology from Brown University and an M.D. from Cornell
University Medical College. He also holds an M.S. in Health
Services from the University of California, Los Angeles.
“I have seen firsthand the trust and relationship patients have
with their pharmacist and the critical role pharmacies serve as the
front door to the healthcare system in most communities,” said Dr.
Shrank. “Walgreens and Boots are trusted brands, and I’m honored to
have the opportunity to work with leadership and the WBA Board of
Directors to advance the company’s vision and strategy to transform
healthcare delivery.”
Earlier this year, WBA announced several new executive
appointments to deepen the company’s healthcare expertise and
position company for accelerated growth.
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated
healthcare, pharmacy and retail leader serving millions of
customers and patients every day, with a 170-year heritage of
caring for communities. A trusted, global innovator in retail
pharmacy with approximately 12,500 locations across the U.S.,
Europe and Latin America, WBA plays a critical role in the
healthcare ecosystem. The Company is reimagining local healthcare
and well-being for all as part of its purpose – to create more
joyful lives through better health. Through dispensing medicines,
improving access to a wide range of health services, providing high
quality health and beauty products and offering anytime, anywhere
convenience across its digital platforms, WBA is shaping the future
of healthcare.
WBA employs more than 330,000 people and has a presence in eight
countries through its portfolio of consumer brands: Walgreens,
Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico.
Additionally, WBA has a portfolio of healthcare-focused investments
located in several countries, including China and the U.S.
The Company is proud of its contributions to healthy
communities, a healthy planet, an inclusive workplace and a
sustainable marketplace. WBA has been recognized for its commitment
to operating sustainably: the Company is an index component of the
Dow Jones Sustainability Indices (DJSI) and was named to the 100
Best Corporate Citizens 2022.
More Company information is available at
www.walgreensbootsalliance.com.
(WBA-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240710216202/en/
WBA Media Relations USA / Jim Cohn, +1 224 813 9057
International, +44 (0)20 7980 8585
WBA Investor Relations Tiffany Kanaga, +1 847 315
2922
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Jul 2023 to Jul 2024